Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

ENTYVIO® Real-World Outcomes in Bio-naïve Crohn's Disease Patients in Belgium, Australia, and Switzerland: An EVOLVE Observational Expansion Study

NCT05056441 is registered in ClinicalTrials.gov with Takeda as lead sponsor.

NCT NCT05056441
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05056441 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
ENTYVIO® Real-World Outcomes in Bio-naïve Crohn's Disease Patients in Belgium, Australia, and Switzerland: An EVOLVE Observational Expansion Study
Lead sponsor
Takeda
Phase
Observational
Overall status
Completed
Start date
December 1, 2021
Completion date
September 30, 2022
Enrollment
623 (actual)
Sites
31

Conditions

As the registry lists them; a condition with its own page is linked.

crohn disease